首页> Blood advances> US Intergroup Study of Chemotherapy Plus Dasatinib and Allogeneic Stem Cell Transplant in Philadelphia Chromosome Positive ALL.

US Intergroup Study of Chemotherapy Plus Dasatinib and Allogeneic Stem Cell Transplant in Philadelphia Chromosome Positive ALL.

导出 LinkOut

翻译打印收藏纠错

第一作者： Farhad,Ravandi

第一单位： Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.

作者： Farhad,Ravandi ^[1] ; Megan,Othus ^[2] ; Susan M,O'Brien ^[3] ; Stephen J,Forman ^[4] ; Chul S,Ha ^[5] ; Jeffrey Y C,Wong ^[4] ; Martin S,Tallman ^[6] ; Elisabeth,Paietta ^[7] ; Janis,Racevskis ^[7] ; Geoffrey L,Uy ^[8] ; Mary,Horowitz ^[9] ; Naoko,Takebe ^[10] ; Richard,Little ^[10] ; Uma,Borate ^[11] ; Partow,Kebriaei ^[12] ; Laura,Kingsbury ^[2] ; Hagop M,Kantarjian ^[1] ; Jerald P,Radich ^[13] ; Harry P,Erba ^[14] ; Frederick R,Appelbaum ^[15]

作者单位： Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX. ^[1] SWOG Statistical Center, Seattle, WA. ^[2] University of California - Irvine, Orange, CA. ^[3] City of Hope National Medical Center, Duarte, CA. ^[4] University of Texas Health Science Center, San Antonio, TX. ^[5] Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY. ^[6] Cancer Center, Montefiore Medical Center, Bronx, NY.;Albert Einstein College of Medicine, New York, NY. ^[7] Division of Oncology, Washington University School of Medicine, St. Louis, MO. ^[8] Medical College of Wisconsin, Milwaukee, WI. ^[9] Cancer Therapy Evaluation Program, Investigational Drug Branch, Bethesda, MD. ^[10] University of Alabama at Birmingham, Birmingham, AL. ^[11] Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX. ^[12] Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA. ^[13] University of Alabama at Birmingham and UAB Comprehensive Cancer Center, Birmingham, AL. ^[14] Fred Hutchinson Cancer Research Center, Seattle, WA. ^[15]

DOI 10.1182/bloodadvances.2016001495

PMID 29046900

发布时间 2021-02-06

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览9

Blood advances

2016年1卷3期

250-259页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览9

点击下载本期目录封面

Blood advances

2016年1卷3期

250-259页

检索历史清除

US Intergroup Study of Chemotherapy Plus Dasatinib and Allogeneic Stem Cell Transplant in Philadelphia Chromosome Positive ALL.

Blood advances

相似文献

同项目论文

Blood advances

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

US Intergroup Study of Chemotherapy Plus Dasatinib and Allogeneic Stem Cell Transplant in Philadelphia Chromosome Positive ALL.

Blood advances

相似文献

同项目论文

Blood advances

相关期刊

检索历史清除